Nadine Chapman-Rothe

Title: Nadine Chapman-Rothe: Innovator in Quinazoline Compounds

Introduction

Nadine Chapman-Rothe is a distinguished inventor based in London, GB. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on quinazoline compounds. Her research focuses on the therapeutic applications of these compounds, which have the potential to impact various diseases.

Latest Patents

Nadine holds a patent for "Quinazoline compounds and their use in therapy." This invention relates to quinazoline compounds of Formula (I), which are inhibitors of the histone lysine methyltransferase (HKMTase) EZH2. The patent outlines the uses of such compounds as medicaments, particularly in the treatment of diseases or disorders where inhibition of EZH2 provides a therapeutic or prophylactic effect. She has 1 patent to her name.

Career Highlights

Throughout her career, Nadine has worked with notable organizations, including Imperial Innovations Limited and Emory University. Her work in these institutions has allowed her to advance her research and collaborate with other experts in the field.

Collaborations

Nadine has collaborated with esteemed colleagues such as Robert Albert Brown and Matthew John Fuchter. These partnerships have contributed to her innovative research and the development of her patented compounds.

Conclusion

Nadine Chapman-Rothe is a prominent figure in the field of medicinal chemistry, with her work on quinazoline compounds showcasing her innovative spirit. Her contributions have the potential to lead to significant advancements in therapeutic applications.